SCHEMBL2846554

SCHEMBL2846554

CC(C)COC1CN(C(=O)OC(C)(C)C)CCC1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PRMT5 O14744 2/20 0.39
WDR77 Q9BQA1 2/20 0.39
GPR119 Q8TDV5 5/20 0.39
NPC1 O15118 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RECQL P46063 1/20 0.39
EPHX1 P07099 1/20 0.39
DPP4 P27487 1/20 0.38
NR1H2 P55055 1/20 0.38
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
USP30 Q70CQ3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2846551 1.00 ALDH1A1 (0.40) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL2850017 0.85 HPGD (0.43) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL2850020 0.85 HPGD (0.43) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL2821605 0.83 HPGD (0.41) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL2844635 0.83 HPGD (0.41) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL2844639 0.83 HPGD (0.41) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL2849139 0.83 HPGD (0.43) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL2849137 0.83 HPGD (0.43) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL2845398 0.82 CTSV (0.39) RAB9ADPP4
SCHEMBL2845392 0.82 CTSV (0.39) RAB9ADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2226322-B1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO CO LTD (JP) 2015-01-21 EP disclosed
US-8927588-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-01-06 US disclosed
US-20140073622-A1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-03-13 US disclosed
US-8536197-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-09-17 US disclosed
US-20100311966-A1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-12-09 US disclosed
EP-2226322-A1 IMIDAZOLE CARBONYL COMPOUND Daiichi Sankyo Company, Limited (JP) 2010-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311966-A1 IMIDAZOLE CARBONYL COMPOUND TOP1, TOP2B, TOP2A ALDH1A1 3596/4885MAPT 1455/4885HPGD 1751/4885
US-20140073622-A1 IMIDAZOLE CARBONYL COMPOUND TOP1, TOP2B, TOP2A ALDH1A1 1220/4885MAPT 1979/4885HPGD 578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.